BioNexus Gene Lab Corp share price logo

BioNexus Gene Lab Corp

NASDAQ: BGLC

$1.39

+0.10

(+7.72%)

as on

BioNexus Gene Lab Corp Stock Performance

as on October 13, 2026 at 2:15 pm IST

  • Day's Low

    $1.27
    $1.39
    downward going graph

    8.63%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.07
    $5.89
    downward going graph

    23.02%

    Downside

    323.57%

    Upside

    downward going graph

BioNexus Gene Lab Corp share price movements today

Previous Close
$1.29
Open
$1.27
Volume
128.2K
Market Cap
$3.8M
Day's Low - High
$1.27 - $1.39
52 Week Low - High
$1.07 - $5.89

BioNexus Gene Lab Corp Historical Returns

1 Month Return
-13.69 %
3 Month Return
-20.14 %
1 Year Return
-73.98 %
3 Year Return
-78.03 %
5 Year Return
0 %

BioNexus Gene Lab Corp Stock Fundamentals & Key Indicators

Check BioNexus Gene Lab Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.8M

EPS (TTM)

-1.26

Dividend Yield

0.00%

PE Ratio (TTM)

-1.02

Industry PE ratio

-4.33

PEG Ratio

-0.09

Return On Equity TTM

-32.91%

BioNexus Gene Lab Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioNexus Gene Lab Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$3.8MNA-1.0211.64%0.00%
StrongBuy$79.0B33.31%37.5844.11%1.04%
NA$30.4BNA41.5854.89%0.24%
Buy$77.5B10.44%29.1749.07%1.00%
StrongBuy$223.0B61.92%31.0937.56%1.30%

Stock Returns calculator for BioNexus Gene Lab Corp Stock including INR - Dollar returns

The BioNexus Gene Lab Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

BioNexus Gene Lab Corp investment value today

Current value as on today

₹28,113

Returns

-₹71,887

(-71.89%)

Returns from BioNexus Gene Lab Corp Stock

-₹73,970 (-73.97%)

Dollar Impact

₹2,083 (+2.08%)

Indian Investors' Interest in BioNexus Gene Lab Corp Stock

Search interest for BioNexus Gene Lab Corp Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-34% versus previous 30 day period

BioNexus Gene Lab Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
2
1
2
2
2
2
2
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
0
0
-1
0
0
0
0
-1
0
0
EBITDA
0
0
-1
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
-
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
-1
0
0
0
0
-1
0
0
Income Tax Expense
0
0
0
0
-
-
-
-
-
-
Net Income
0
0
-1
0
0
0
0
-1
0
0
Net Profit Margin
15.33%
14.62%
12.41%
12.25%
16.07%
16.28%
14.85%
-0.82%
-99.51%
17.05%

BioNexus Gene Lab Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
11
13
10
9
9
7
Gross Profit
0
0
0
1
2
1
1
1
1
Operating Income
0
0
0
1
1
0
-2
-1
-3
EBITDA
0
0
0
1
1
0
-2
-1
-2
Interest Expense
-
-
-
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
0
1
1
0
-2
-1
-2
Income Tax Expense
0
0
0
0
0
0
0
0
-
Net Income
0
0
0
1
0
0
-2
-1
-2
Net Profit Margin
73.19%
13.55%
44.02%
15.10%
16.42%
11.52%
13.61%
13.56%
14.62%

BioNexus Gene Lab Corp Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
0
-1
0
0
0
0
-1
0
0
Operating Cash Flow
0
0
-1
0
0
0
-1
0
0
0
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
0
0
0
0
0
0
0
Change in Cash
0
0
-1
0
0
0
0
1
0
-1

BioNexus Gene Lab Corp Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
0
1
0
0
-2
-1
-2
Operating Cash Flow
0
0
0
0
0
0
-1
-2
-1
Investing Cash Flow
-5
0
0
1
0
0
-1
0
0
Financing Cash Flow
5
0
0
0
0
0
6
0
0
Change in Cash
0
0
0
1
0
0
3
-1
0

Global Institutional Holdings in BioNexus Gene Lab Corp

Check out the Institutions with significant holdings in BioNexus Gene Lab Corp.

Funds
Holdings
Fidelity Concord Street Trust
0.08%

Insights on BioNexus Gene Lab Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BGLC stock has moved up by 12.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 22.84K → 76.15K (in $), with an average increase of 70.0% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -1.03M → -286.45K (in $), with an average increase of 90.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Air Products & Chemicals, Inc. has given 8.8% return, outperforming this stock by 82.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, BioNexus Gene Lab Corp Common stock has experienced a drawdown of -78.0%, however Ecolab, Inc. resisted the overall trend and outperformed by 77.4%

About BioNexus Gene Lab Corp

BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
OrganisationBioNexus Gene Lab Corp
HeadquartersMenara UOA Bangsar, Kuala Lumpur, WP, 59000, MY
IndustryIndustrial - Distribution
CEOSu-Leng Tan

Key Management of BioNexus Gene Lab Corp

Name

Title

Mr. Too Kam Tham

Managing Director

Mr. Su-Leng Tan

CEO, President, Secretary & Director

Ms. Set Fui Chong

Chief Financial Officer

Mr. Kwan Wah Chan

Marketing Manager

FAQs

What is BioNexus Gene Lab Corp share price today?

BioNexus Gene Lab Corp share price today is $1.39 as on at the close of the market. BioNexus Gene Lab Corp share today touched a day high of $1.39 and a low of $1.27.

What is the 52 week high and 52 week low for BioNexus Gene Lab Corp share?

BioNexus Gene Lab Corp share touched a 52 week high of $5.89 on and a 52 week low of $1.07 on . BioNexus Gene Lab Corp stock price today i.e. is closed at $1.39,which is 76.39% down from its 52 week high and 29.91% up from its 52 week low.

What is BioNexus Gene Lab Corp's market capitalisation today?

BioNexus Gene Lab Corp market capitalisation is $0.00T as on .

How to invest in BioNexus Gene Lab Corp Stock (BGLC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioNexus Gene Lab Corp on INDmoney app. Click on Buy button.

What is the minimum amount required to buy BioNexus Gene Lab Corp Stock (BGLC) from India?

Indian investors can start investing in BioNexus Gene Lab Corp (BGLC) shares with as little as ₹95.76000213623047 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in BioNexus Gene Lab Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on BioNexus Gene Lab Corp share’s latest price of $1.39 as on October 13, 2026 at 8:45 am IST, you will get 7.1942 shares of BioNexus Gene Lab Corp. Learn more about fractional shares .